DermTech to Present at the William Blair Growth Stock Conference

LA JOLLA, Calif.--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that management is scheduled to present at the William Blair Growth Stock Conference on Wednesday, June 8, 2022 at 2:00 p.m. CT. A live webcast of the presentation will be available on the investor relations section of DermTech's website at https://investors.dermtech.com/news-events/events. A replay of the webcast will be archived for 90 days following the conference.

About DermTech

DermTech is a leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non-invasive skin genomics platform. DermTech’s mission is to improve the lives of millions by providing non-invasive precision dermatology solutions that enable individualized care. DermTech provides genomic analysis of skin samples collected non-invasively using our Smart StickersTM. DermTech markets and develops products that facilitate the early detection of skin cancers and is developing products that assess inflammatory diseases and customize drug treatments. For additional information, please visit DermTech.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220601005048/en/

Steve Kunszabo
DermTech
(858) 291-1647
[email protected]

Source: DermTech, Inc.

You May Also Be Interested In

• KBRA Upgrades State of New Jersey General Obligation Bonds to AA- and Appropriation Bonds to A+; Assigns A+ Rating to New Jersey Transportation Trust Fund Authority Transportation Program Bonds, 2026
• Heartvue.ai and Innolitics Achieve FDA 510(k) Clearance for Heartvue.Proton, an AI-Powered Cardiac MRI Analysis Platform
• 7 Wolves Consulting Announces Release of Founder Danielle D. Pollard's Debut Book, Act Like a Lady, Speak Like a Wolf